Current Cancer Drug Targets
Title: Editorial [Hot Topic:Targeting Tumor Stroma (Guest Editors: Marc G. Achen and Steven A. Stacker)]
Volume: 8 Issue: 6
Author(s): Marc G. Achen and Steven A. Stacker
Affiliation:
Export Options
About this article
Cite this article as:
Achen G. Marc and Stacker A. Steven, Editorial [Hot Topic:Targeting Tumor Stroma (Guest Editors: Marc G. Achen and Steven A. Stacker)], Current Cancer Drug Targets 2008; 8 (6) . https://dx.doi.org/10.2174/156800908785699397
DOI https://dx.doi.org/10.2174/156800908785699397 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Related Books
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
CDK9: Therapeutic Perspective in HCC Therapy
Current Cancer Drug Targets Alternative Splicing: A Promising Target for Pharmaceutical Inhibition of Pathological Angiogenesis?
Current Pharmaceutical Design Association of flavonoid-rich foods and statins in the management of hypercholesterolemia: a dangerous or helpful combination?
Current Drug Metabolism mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy
Current Cancer Drug Targets Xanthones from Mangosteen Extracts as Natural Chemopreventive Agents: Potential Anticancer Drugs
Current Molecular Medicine Erythropoietin: New Approaches to Improved Molecular Designs and Therapeutic Alternatives
Current Pharmaceutical Design Improved Prediction of Lysine Acetylation by Support Vector Machines
Protein & Peptide Letters Mitochondria as a Target for Exercise-Induced Cardioprotection
Current Drug Targets Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies
Current Drug Therapy Release Kinetics from Bio-Polymeric Nanoparticles Encapsulating Protein Synthesis Inhibitor- Cycloheximide, for Possible Therapeutic Applications
Current Pharmaceutical Biotechnology Molecular Modeling of Sulfonylmorpholinopyrimidines as the Ataxia Telangiectasis Mutated and RAD3-related (ATR) Protein Kinase Inhibitors by Computational Explorations
Letters in Drug Design & Discovery Synthesis of Tetrahydrobenzo[b]thiophene-3-carbohydrazide Derivatives as Potential Anti-cancer Agents and Pim-1 Kinase Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Paris polyphylla: Chemical and Biological Prospectives
Anti-Cancer Agents in Medicinal Chemistry EDITORIAL: Novel Signaling Pathway Based Therapeutics in Cancer and Other Diseases
Current Signal Transduction Therapy Cubilin, the Intrinsic Factor-Vitamin B12 Receptor in Development and Disease
Current Medicinal Chemistry Epithelial Cell Signaling in Helicobacter pylori Infection
Current Signal Transduction Therapy Chemogenomics of Sensitivity and Resistance to Anticancer Drugs
Current Pharmacogenomics Recent Developments of Phototherapy Based on Graphene Family Nanomaterials
Current Medicinal Chemistry Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies
Clinical Cancer Drugs Modulation of the TRPV1 Channel: Current Clinical Trials and Recent Patents with Focus on Neurological Conditions
Recent Patents on CNS Drug Discovery (Discontinued)